ITMI20051415A1 - Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione - Google Patents

Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione

Info

Publication number
ITMI20051415A1
ITMI20051415A1 ITMI20051415A ITMI20051415A1 IT MI20051415 A1 ITMI20051415 A1 IT MI20051415A1 IT MI20051415 A ITMI20051415 A IT MI20051415A IT MI20051415 A1 ITMI20051415 A1 IT MI20051415A1
Authority
IT
Italy
Prior art keywords
corbossimethylcellulose
antimicrobial
salt
production process
acid derivatives
Prior art date
Application number
Other languages
English (en)
Inventor
Davide Bellini
Alessandra Pavesio
Massimo Terrassan
Original Assignee
Fidia Advanced Biopolymers Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Advanced Biopolymers Srl filed Critical Fidia Advanced Biopolymers Srl
Priority to ITMI20051415 priority Critical patent/ITMI20051415A1/it
Priority to BRPI0613606-0A priority patent/BRPI0613606A2/pt
Priority to RU2008102250/15A priority patent/RU2008102250A/ru
Priority to AT06762656T priority patent/ATE418348T1/de
Priority to MX2008000969A priority patent/MX2008000969A/es
Priority to EP20060762656 priority patent/EP1922089B1/en
Priority to CA 2616025 priority patent/CA2616025A1/en
Priority to KR1020087001631A priority patent/KR20080036584A/ko
Priority to JP2008521865A priority patent/JP2009505687A/ja
Priority to DE200660004466 priority patent/DE602006004466D1/de
Priority to PCT/EP2006/007019 priority patent/WO2007009728A2/en
Priority to US11/989,224 priority patent/US20090233509A1/en
Publication of ITMI20051415A1 publication Critical patent/ITMI20051415A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/225—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/208—Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2913—Rod, strand, filament or fiber
    • Y10T428/2973—Particular cross section
    • Y10T428/2976—Longitudinally varying
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T442/00—Fabric [woven, knitted, or nonwoven textile or cloth, etc.]
    • Y10T442/50—FELT FABRIC
    • Y10T442/56—From synthetic organic fiber
ITMI20051415 2005-07-22 2005-07-22 Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione ITMI20051415A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
ITMI20051415 ITMI20051415A1 (it) 2005-07-22 2005-07-22 Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione
BRPI0613606-0A BRPI0613606A2 (pt) 2005-07-22 2006-07-17 biomateriais na forma de feltros de não tecido, processo para a preparação e uso dos mesmos e fibras
RU2008102250/15A RU2008102250A (ru) 2005-07-22 2006-07-17 Биоматериалы на основе цинковой соли карбоксиметилцеллюлозы в сочетании с производным гиалуроновой кислоты для применения в качестве медицинских средств с антимикробной и противогрибковой активностью и способ их получения
AT06762656T ATE418348T1 (de) 2005-07-22 2006-07-17 Biomaterialien auf der basis von carboxymethylcellulose in zinksalzform in assoziation mit hyaluronsäurederivaten
MX2008000969A MX2008000969A (es) 2005-07-22 2006-07-17 Biomateriales a base de carboximetilcelulosa salificada con zinc asociado con derivados de acido hialuronico.
EP20060762656 EP1922089B1 (en) 2005-07-22 2006-07-17 Biomaterials based on carboxymethylcellulose salified with zinc associated with hyaluronic acid derivatives
CA 2616025 CA2616025A1 (en) 2005-07-22 2006-07-17 Biomaterials based on carboxymethylcellulose salified with zinc associated with hyaluronic acid derivatives
KR1020087001631A KR20080036584A (ko) 2005-07-22 2006-07-17 히알루론산 유도체와 결합된 아연에 의해 염화된카르복시메틸셀룰로오스를 기반으로 한 생체물질
JP2008521865A JP2009505687A (ja) 2005-07-22 2006-07-17 抗菌活性および抗真菌活性を有する医療機器として使用するための、ヒアルロン酸誘導体と組み合わせた、亜鉛で塩化したカルボキシメチルセルロースをベースとする生体材料、ならびにその製造方法
DE200660004466 DE602006004466D1 (de) 2005-07-22 2006-07-17 Biomaterialien auf der basis von carboxymethylcellulose in zinksalzform in assoziation mit hyaluronsäurederivaten
PCT/EP2006/007019 WO2007009728A2 (en) 2005-07-22 2006-07-17 Biomaterials based on carboxymethylcellulose salified with zinc associated with hyaluronic acid derivatives
US11/989,224 US20090233509A1 (en) 2005-07-22 2006-07-17 Biomaterials Based On Carboxymethylcellulose Salified With Zinc Associated With Hyaluronic Acid Derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI20051415 ITMI20051415A1 (it) 2005-07-22 2005-07-22 Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione

Publications (1)

Publication Number Publication Date
ITMI20051415A1 true ITMI20051415A1 (it) 2007-01-23

Family

ID=37669160

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI20051415 ITMI20051415A1 (it) 2005-07-22 2005-07-22 Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione

Country Status (12)

Country Link
US (1) US20090233509A1 (it)
EP (1) EP1922089B1 (it)
JP (1) JP2009505687A (it)
KR (1) KR20080036584A (it)
AT (1) ATE418348T1 (it)
BR (1) BRPI0613606A2 (it)
CA (1) CA2616025A1 (it)
DE (1) DE602006004466D1 (it)
IT (1) ITMI20051415A1 (it)
MX (1) MX2008000969A (it)
RU (1) RU2008102250A (it)
WO (1) WO2007009728A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2009836A3 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Derivát kyseliny hyaluronové oxidovaný v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd, zpusob jeho prípravy a zpusob jeho modifikace
CZ302503B6 (cs) 2009-12-11 2011-06-22 Contipro C A.S. Zpusob prípravy derivátu kyseliny hyaluronové oxidovaného v poloze 6 glukosaminové cásti polysacharidu selektivne na aldehyd a zpusob jeho modifikace
US9308219B2 (en) * 2011-06-30 2016-04-12 Collagen Matrix, Inc. Flat self-curling permeable sheet membrane
CZ2012136A3 (cs) 2012-02-28 2013-06-05 Contipro Biotech S.R.O. Deriváty na bázi kyseliny hyaluronové schopné tvorit hydrogely, zpusob jejich prípravy, hydrogely na bázi techto derivátu, zpusob jejich prípravy a pouzití
CZ304512B6 (cs) 2012-08-08 2014-06-11 Contipro Biotech S.R.O. Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
CZ304303B6 (cs) 2012-11-27 2014-02-19 Contipro Biotech S.R.O. Vlákna založená na hydrofobizovaném hyaluronanu, způsob jejich přípravy a použití, textilie na jejich bázi a použití
CZ304654B6 (cs) 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
CZ2014150A3 (cs) 2014-03-11 2015-05-20 Contipro Biotech S.R.O. Konjugáty oligomeru kyseliny hyaluronové nebo její soli, způsob jejich přípravy a použití
CZ2014451A3 (cs) 2014-06-30 2016-01-13 Contipro Pharma A.S. Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití
CZ309295B6 (cs) 2015-03-09 2022-08-10 Contipro A.S. Samonosný, biodegradabilní film na bázi hydrofobizované kyseliny hyaluronové, způsob jeho přípravy a použití
CZ306479B6 (cs) 2015-06-15 2017-02-08 Contipro A.S. Způsob síťování polysacharidů s využitím fotolabilních chránicích skupin
CZ306662B6 (cs) 2015-06-26 2017-04-26 Contipro A.S. Deriváty sulfatovaných polysacharidů, způsob jejich přípravy, způsob jejich modifikace a použití
CZ308106B6 (cs) 2016-06-27 2020-01-08 Contipro A.S. Nenasycené deriváty polysacharidů, způsob jejich přípravy a jejich použití
EP3722324A4 (en) 2017-12-07 2021-09-29 Nippon Paper Industries Co., Ltd. CARBOXYMETHYLATED CELLULOSE NANOFIBERS
WO2019111934A1 (ja) * 2017-12-07 2019-06-13 日本製紙株式会社 カルボキシメチル化セルロース
WO2019111928A1 (ja) 2017-12-07 2019-06-13 日本製紙株式会社 カルボキシメチル化セルロースナノファイバーの製造方法
CN108939056A (zh) * 2018-07-25 2018-12-07 张河 一种生物多糖冲洗胶液及其制备方法
WO2021141748A1 (en) * 2020-01-08 2021-07-15 Lifescienceplus, Inc. Compositions and methods for tissue regeneration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
GB9421653D0 (en) * 1994-10-27 1994-12-14 Innovative Tech Ltd Wound dressing
IT1294797B1 (it) * 1997-07-28 1999-04-15 Fidia Advanced Biopolymers Srl Uso dei derivati dell'acido ialuronico nella preparazione di biomateriali aventi attivita' emostatica fisica e tamponante
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
GB0107655D0 (en) * 2001-03-27 2001-05-16 Bristol Myers Squibb Co Wound dressing
GB0107653D0 (en) * 2001-03-27 2001-05-16 Bristol Myers Squibb Co Wound dressing

Also Published As

Publication number Publication date
WO2007009728A3 (en) 2007-06-07
ATE418348T1 (de) 2009-01-15
CA2616025A1 (en) 2007-01-25
US20090233509A1 (en) 2009-09-17
MX2008000969A (es) 2008-03-27
EP1922089B1 (en) 2008-12-24
WO2007009728A2 (en) 2007-01-25
JP2009505687A (ja) 2009-02-12
KR20080036584A (ko) 2008-04-28
RU2008102250A (ru) 2009-07-27
DE602006004466D1 (de) 2009-02-05
BRPI0613606A2 (pt) 2011-01-18
EP1922089A2 (en) 2008-05-21

Similar Documents

Publication Publication Date Title
ITMI20051415A1 (it) Biomateriali a base di corbossimetilcellulosa salificata con zinco associata a derivati dell'acido ialuronico da impiegarsi come dispositivi medici con attivita' antimicrobica ed antifungina e loro processo di produzione
NZ599399A (en) A scaffold material for wound care and/or other tissue healing applications
MY147864A (en) Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
MX2012002746A (es) Vendajes medicos antimicrobianos y proteccion de heridas y sitios de cateter.
WO2011127188A3 (en) Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
SG127802A1 (en) Polymeric hydrogel compositions
ITPD20050207A1 (it) Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
FR2978665B1 (fr) Composition antiseptique
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
ATE538775T1 (de) Ketorolac-tromethamin-zusammensetzungen zur behandlung oder prävention von schmerz
MX2019007572A (es) Composiciones que comprenden acido acetico y acido hipocloroso y metodos para tratar biopelicula.
ATE437988T1 (de) Neues imprägnierverfahren einer textiloberfläche
ATE446098T1 (de) Verwendung von polyethylenglycol bei entzündungsbedingten topischen erkrankungen oder erkrankungen und wundheilung
WO2012086988A3 (en) Artificial silk membrane having excellent flexibility and suturing ability and method of manufacturing the same
CL2008001282A1 (es) Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria.
MX2015015379A (es) Agonistas alfa adrenergicos para el tratamiento de traumatismo de tejidos.
WO2015054377A3 (en) Essential oils or volatile organics thereof electrospun in chitosan nanofiber mats
SE0401943D0 (sv) New use
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
RU2007139427A (ru) Способ предпосевной обработки семян овощных культур
DE50012667D1 (de) Verwendung von 2-amino-3,4-dihydro-chinazolinen zur herstellung eines medikaments zur behandlung oder prophylaxe von ischämischen zuständen
Pankhurst Heavily exuding venous leg ulcer with suspected biofilm.
Anand et al. Development of composite textile structures for wound dressing applications
CN109200335A (zh) 医用壳聚糖伤口敷料
PH22017000864Y1 (en) AN ANTIBACTERIAL HYDROGEL WOUND SPRAY FROM Musa sapientum (BANANA) STEM SAP